HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer

Hanlin Ma(Qilu Hospital of Shandong University), Beihua Kong(Qilu Hospital of Shandong University), Gonghua Qi(Qilu Hospital of Shandong University), Wei Lu(Huawei Technologies (China)), Cunzhong Yuan(Qilu Hospital of Shandong University), Rongrong Li(Qilu Hospital of Shandong University), Fang Han(Qilu Hospital of Shandong University), Jia Yan(Qilu Hospital of Shandong University), Yan Shi(Qilu Hospital of Shandong University)
Cell Death and Disease
March 24, 2022
10.1038/s41419-022-04670-7
Cited by 48

Related Papers

Dual-Targeting Upconversion Nanoprobes across the Blood–Brain Barrier for Magnetic Resonance/Fluorescence Imaging of Intracranial Glioblastoma
|ACS Nano|2014|302
A fully biodegradable and self-electrified device for neuroregenerative medicine
|Science Advances|2020|188
"Little brothers watching you"
|Unknown|2013|180
Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer
|Nanotechnology|2011|176
TANKBind: Trigonometry-Aware Neural NetworKs for Drug-Protein Binding Structure Prediction
|bioRxiv (Cold Spring Harbor Laboratory)|2022|166